6 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Here's What Key Metrics Tell Us About BioMarin (BMRN) Q4 Earnings https://www.zacks.com/stock/news/2230527/here-s-what-key-metrics-tell-us-about-biomarin-bmrn-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2230527 Feb 22, 2024 - Although the revenue and EPS for BioMarin (BMRN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Merus N.V. (MRUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? https://www.zacks.com/stock/news/2228608/merus-n-v-mrus-expected-to-beat-earnings-estimates-can-the-stock-move-higher?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2228608 Feb 20, 2024 - Merus N.V. (MRUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Seeking Clues to BioMarin (BMRN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics https://www.zacks.com/stock/news/2227844/seeking-clues-to-biomarin-bmrn-q4-earnings-a-peek-into-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2227844 Feb 19, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for BioMarin (BMRN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
GSK Gears Up for Q4 Earnings: Will It Surpass Estimates? https://www.zacks.com/stock/news/2217328/gsk-gears-up-for-q4-earnings-will-it-surpass-estimates?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217328 Jan 29, 2024 - We expect GSK's specialty products like Arexvy, Cabenuva, Dovato, Bexsero, Trelegy Ellipta and Shingrix to drive fourth-quarter sales performance.
Here's Why Investors May Bet on BioMarin (BMRN) Stock Now https://www.zacks.com/stock/news/2215118/here-s-why-investors-may-bet-on-biomarin-bmrn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2215118 Jan 24, 2024 - Here, we discuss some reasons why investing in BioMarin (BMRN) stock now may turn out to be a more prudent move than ever.
Centene (CNC) Chosen to Serve New Hampshire's Medicaid Members https://www.zacks.com/stock/news/2212996/centene-cnc-chosen-to-serve-new-hampshire-s-medicaid-members?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2212996 Jan 19, 2024 - Centene's (CNC) subsidiary has been selected by the DHHS to serve the diversified health needs of members of New Hampshire's Medicaid program and thereby, earn more members.

Pages: 1

Page 1